Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

× No keyword cloud information.

163 in total

Review 1. Management of hepatitis B in special populations.

Authors: Kali Zhou; Norah Terrault
Journal: Best Pract Res Clin Gastroenterol Date: 2017-06-08 Impact factor: 3.043

2. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.

Authors: Arpan Patel; Suna Yapali; Anna S F Lok
Journal: Hepatol Int Date: 2015-08-14 Impact factor: 6.047

Review 3. Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.

Authors: Tiffany Wu; Ryan M Kwok; Tram T Tran
Journal: Am J Gastroenterol Date: 2017-10-31 Impact factor: 10.864

Review 4. Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.

Authors: Rohit Loomba; T Jake Liang
Journal: Gastroenterology Date: 2017-02-20 Impact factor: 22.682

5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors: Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal: Hepatology Date: 2018-04 Impact factor: 17.425

Review 6. KASL clinical practice guidelines for management of chronic hepatitis B.

Authors:
Journal: Clin Mol Hepatol Date: 2019-06-12

7. Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.

Authors: Marco Picardi; Roberta Della Pepa; Claudia Giordano; Irene Zacheo; Novella Pugliese; Chiara Mortaruolo; Fabio Trastulli; Antonio Giordano; Mariano Lucignano; Maria Di Perna; Marta Raimondo; Claudia Salvatore; Fabrizio Pane
Journal: Blood Date: 2018-12-07 Impact factor: 22.113

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.